China Universal Asset Management Co. Ltd. Purchases 3,487 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

China Universal Asset Management Co. Ltd. grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating) by 21.9% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 19,425 shares of the medical equipment provider’s stock after acquiring an additional 3,487 shares during the quarter. Intuitive Surgical accounts for approximately 2.1% of China Universal Asset Management Co. Ltd.’s investment portfolio, making the stock its 14th biggest position. China Universal Asset Management Co. Ltd.’s holdings in Intuitive Surgical were worth $5,860,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the stock. Hexagon Capital Partners LLC boosted its holdings in Intuitive Surgical by 200.0% in the 4th quarter. Hexagon Capital Partners LLC now owns 69 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 46 shares during the period. Paragon Capital Management Ltd acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $26,000. Hanseatic Management Services Inc. boosted its stake in shares of Intuitive Surgical by 200.0% in the fourth quarter. Hanseatic Management Services Inc. now owns 72 shares of the medical equipment provider’s stock valued at $26,000 after buying an additional 48 shares during the period. Standard Family Office LLC acquired a new stake in Intuitive Surgical during the fourth quarter worth approximately $27,000. Finally, Wolff Wiese Magana LLC increased its stake in Intuitive Surgical by 1,000.0% during the 4th quarter. Wolff Wiese Magana LLC now owns 77 shares of the medical equipment provider’s stock worth $28,000 after acquiring an additional 70 shares during the period. Institutional investors and hedge funds own 83.69% of the company’s stock.

In other news, EVP Myriam Curet sold 6,000 shares of the stock in a transaction dated Tuesday, April 26th. The stock was sold at an average price of $252.51, for a total value of $1,515,060.00. Following the completion of the sale, the executive vice president now owns 361 shares of the company’s stock, valued at $91,156.11. The sale was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 0.90% of the company’s stock.

ISRG opened at $206.75 on Wednesday. Intuitive Surgical, Inc. has a fifty-two week low of $186.83 and a fifty-two week high of $369.69. The company’s 50 day moving average price is $215.38 and its two-hundred day moving average price is $268.84. The firm has a market capitalization of $74.21 billion, a price-to-earnings ratio of 45.98, a PEG ratio of 4.59 and a beta of 1.27.

Intuitive Surgical (NASDAQ:ISRGGet Rating) last issued its quarterly earnings data on Thursday, April 21st. The medical equipment provider reported $1.00 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.07. The company had revenue of $1.49 billion for the quarter, compared to analysts’ expectations of $1.43 billion. Intuitive Surgical had a net margin of 27.84% and a return on equity of 14.16%. Intuitive Surgical’s revenue for the quarter was up 15.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.17 earnings per share. As a group, research analysts expect that Intuitive Surgical, Inc. will post 4.24 EPS for the current fiscal year.

Several analysts have recently issued reports on the company. Truist Financial started coverage on Intuitive Surgical in a report on Tuesday, April 12th. They set a “buy” rating and a $360.00 target price on the stock. Piper Sandler reiterated a “buy” rating and set a $316.00 price objective on shares of Intuitive Surgical in a research note on Friday, June 3rd. Royal Bank of Canada assumed coverage on shares of Intuitive Surgical in a report on Friday, March 25th. They set an “outperform” rating and a $340.00 price target for the company. StockNews.com began coverage on shares of Intuitive Surgical in a research note on Thursday, March 31st. They issued a “hold” rating on the stock. Finally, Wolfe Research started coverage on Intuitive Surgical in a research note on Tuesday, April 5th. They set a “peer perform” rating and a $315.00 target price for the company. Seven research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $323.24.

About Intuitive Surgical (Get Rating)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Articles

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.